(CBS Denver) – New questions are being raised about whether or not people who have had COVID-19 need two doses of the coronavirus vaccines. CBS Denver Medical Editor Dr. Dave Hnida addressed it during his weekly question & answer session on CBSN Denver.
“At this point the advice remains the same,” he said, referring to the vaccines which require two doses. “It’s going to be two vaccinations even if you have had COVID in the past. We just don’t know how strong and how long your immune response is from illness.”
READ MORE: 'COVID Bandit' Gives $200 Tip To Every Single Employee At Denver SteakhouseHnida did point to new research released in the past two weeks with a number of studies focused on the immune response to the vaccine in people who have already had COVID.
“It turns out, simply one single vaccine does wind up increasing the antibodies against COVID over a thousandfold. Not only is the antibody response large, it appears to generate a very strong and robust response in terms of being to able to fight off the things such as the mutated strains or variants.”
READ MORE: Kyrie Irving Pushes For Kobe Bryant To Be On NBA Logo“This is almost like you’re getting a ‘Terminator’-type of antibody response, which is really good.”
Hnida said this shows the vaccine is not only safe but effective and important, even if you’ve already had COVID.
MORE NEWS: Police: Man Falsely Reports His Vehicle As Stolen, Googles 'How To Set Your Car On Fire And Make It Look Like An Accident'He explained the questions about a second dose all revolve around having enough vaccine to go around, but for now the recommendation will remain at two doses.
"type" - Google News
February 27, 2021 at 09:00PM
https://ift.tt/3kvNXt2
COVID Vaccine May Create ‘Terminator’-Type Antibody Response In People Who Have Had Coronavirus - CBS Baltimore
"type" - Google News
https://ift.tt/2WhN8Zg
https://ift.tt/2YrjQdq
Bagikan Berita Ini
0 Response to "COVID Vaccine May Create ‘Terminator’-Type Antibody Response In People Who Have Had Coronavirus - CBS Baltimore"
Post a Comment